156 related articles for article (PubMed ID: 28102776)
41. Developing combination of artesunate with paclitaxel loaded into poly-d,l-lactic-co-glycolic acid nanoparticle for systemic delivery to exhibit synergic chemotherapeutic response.
Tran BN; Nguyen HT; Kim JO; Yong CS; Nguyen CN
Drug Dev Ind Pharm; 2017 Dec; 43(12):1952-1962. PubMed ID: 28724314
[TBL] [Abstract][Full Text] [Related]
42. Construction of redox-responsive tumor targeted cisplatin nano-delivery system for effective cancer chemotherapy.
Jia YY; Zhang JJ; Zhang YX; Wang W; Li C; Zhou SY; Zhang BL
Int J Pharm; 2020 Apr; 580():119190. PubMed ID: 32151664
[TBL] [Abstract][Full Text] [Related]
43. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
44. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
45. Nano-Strategies Targeting the Integrin αvβ3 Network for Cancer Therapy.
Cheng TM; Chang WJ; Chu HY; De Luca R; Pedersen JZ; Incerpi S; Li ZL; Shih YJ; Lin HY; Wang K; Whang-Peng J
Cells; 2021 Jul; 10(7):. PubMed ID: 34359854
[TBL] [Abstract][Full Text] [Related]
46. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
[TBL] [Abstract][Full Text] [Related]
47. A poly(γ, L-glutamic acid)-citric acid based nanoconjugate for cisplatin delivery.
Xiong Y; Jiang W; Shen Y; Li H; Sun C; Ouahab A; Tu J
Biomaterials; 2012 Oct; 33(29):7182-93. PubMed ID: 22795851
[TBL] [Abstract][Full Text] [Related]
48. Anticancer activity of cisplatin-loaded PLGA-mPEG nanoparticles on LNCaP prostate cancer cells.
Gryparis EC; Hatziapostolou M; Papadimitriou E; Avgoustakis K
Eur J Pharm Biopharm; 2007 Aug; 67(1):1-8. PubMed ID: 17303395
[TBL] [Abstract][Full Text] [Related]
49.
Godugu K; Mousa SA; Glinsky GV; Lin HY; Davis PJ
Front Endocrinol (Lausanne); 2022; 13():745327. PubMed ID: 35311239
[TBL] [Abstract][Full Text] [Related]
50. In vitro and in vivo evaluation of drug-eluting microspheres designed for transarterial chemoembolization therapy.
Wang Y; Molin DG; Sevrin C; Grandfils C; van den Akker NM; Gagliardi M; Knetsch ML; Delhaas T; Koole LH
Int J Pharm; 2016 Apr; 503(1-2):150-62. PubMed ID: 26965198
[TBL] [Abstract][Full Text] [Related]
51. Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells.
Wang H; Agarwal P; Zhao S; Xu RX; Yu J; Lu X; He X
Biomaterials; 2015 Dec; 72():74-89. PubMed ID: 26344365
[TBL] [Abstract][Full Text] [Related]
52. Targeted and controlled drug delivery system loading artersunate for effective chemotherapy on CD44 overexpressing cancer cells.
Tran TH; Nguyen TD; Van Nguyen H; Nguyen HT; Kim JO; Yong CS; Nguyen CN
Arch Pharm Res; 2016 May; 39(5):687-94. PubMed ID: 27015824
[TBL] [Abstract][Full Text] [Related]
53. Electrohydrodynamic encapsulation of cisplatin in poly (lactic-co-glycolic acid) nanoparticles for controlled drug delivery.
Parhizkar M; Reardon PJ; Knowles JC; Browning RJ; Stride E; Barbara PR; Harker AH; Edirisinghe M
Nanomedicine; 2016 Oct; 12(7):1919-1929. PubMed ID: 27184098
[TBL] [Abstract][Full Text] [Related]
54. Improved delivery of the natural anticancer drug tetrandrine.
Shi C; Ahmad Khan S; Wang K; Schneider M
Int J Pharm; 2015 Feb; 479(1):41-51. PubMed ID: 25510598
[TBL] [Abstract][Full Text] [Related]
55. Quercetin-loaded poly (lactic-co-glycolic acid)-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for the targeted treatment of liver cancer.
Guan X; Gao M; Xu H; Zhang C; Liu H; Lv L; Deng S; Gao D; Tian Y
Drug Deliv; 2016 Nov; 23(9):3307-3318. PubMed ID: 27067032
[TBL] [Abstract][Full Text] [Related]
56. A Promising Emodin-Loaded Poly (Lactic-Co-Glycolic Acid)-d-α-Tocopheryl Polyethylene Glycol 1000 Succinate Nanoparticles for Liver Cancer Therapy.
Liu H; Gao M; Xu H; Guan X; Lv L; Deng S; Zhang C; Tian Y
Pharm Res; 2016 Jan; 33(1):217-36. PubMed ID: 26334502
[TBL] [Abstract][Full Text] [Related]
57. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells.
Yallapu MM; Gupta BK; Jaggi M; Chauhan SC
J Colloid Interface Sci; 2010 Nov; 351(1):19-29. PubMed ID: 20627257
[TBL] [Abstract][Full Text] [Related]
58. Novel Nano-Therapeutic Approach Actively Targets Human Ovarian Cancer Stem Cells after Xenograft into Nude Mice.
Abou-ElNaga A; Mutawa G; El-Sherbiny IM; Abd-ElGhaffar H; Allam AA; Ajarem J; Mousa SA
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417924
[TBL] [Abstract][Full Text] [Related]
59. Tumor targeting using polyamidoamine dendrimer-cisplatin nanoparticles functionalized with diglycolamic acid and herceptin.
Kesavan A; Ilaiyaraja P; Sofi Beaula W; Veena Kumari V; Sugin Lal J; Arunkumar C; Anjana G; Srinivas S; Ramesh A; Rayala SK; Ponraju D; Venkatraman G
Eur J Pharm Biopharm; 2015 Oct; 96():255-63. PubMed ID: 26277659
[TBL] [Abstract][Full Text] [Related]
60. Synthesis and in vitro study of cisplatin-loaded Fe3O4 nanoparticles modified with PLGA-PEG6000 copolymers in treatment of lung cancer.
Nejati-Koshki K; Mesgari M; Ebrahimi E; Abbasalizadeh F; Fekri Aval S; Khandaghi AA; Abasi M; Akbarzadeh A
J Microencapsul; 2014; 31(8):815-23. PubMed ID: 25090589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
